These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17456625)

  • 1. Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapy.
    Stine KC; Saylors RL; Saccente CS; Becton DL
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):161-5. PubMed ID: 17456625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep venous thrombosis in children and adolescents.
    Levy ML; Granville RC; Hart D; Meltzer H
    J Neurosurg; 2004 Aug; 101(1 Suppl):32-7. PubMed ID: 16206969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
    Heidenreich C; Hohmann V; Bramlage P
    Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy.
    Tousovska K; Zapletal O; Skotakova J; Bukac J; Sterba J
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):583-9. PubMed ID: 19620843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
    Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
    Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-patient treatment of acute deep vein thrombosis.
    Mattiasson I; Berntorp E; Bornhov S; Lagerstedt C; Lethagen S; Persson J; Timberg I; Torstensson I
    Int Angiol; 1998 Sep; 17(3):146-50. PubMed ID: 9821026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration.
    Schobess R; Düring C; Bidlingmaier C; Heinecke A; Merkel N; Nowak-Göttl U
    Haematologica; 2006 Dec; 91(12):1701-4. PubMed ID: 17145610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation.
    Zangari M; Barlogie B; Anaissie E; Saghafifar F; Eddlemon P; Jacobson J; Lee CK; Thertulien R; Talamo G; Thomas T; Van Rhee F; Fassas A; Fink L; Tricot G
    Br J Haematol; 2004 Sep; 126(5):715-21. PubMed ID: 15327525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
    Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
    Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study.
    Agnelli G; Gallus A; Goldhaber SZ; Haas S; Huisman MV; Hull RD; Kakkar AK; Misselwitz F; Schellong S;
    Circulation; 2007 Jul; 116(2):180-7. PubMed ID: 17576867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel uses of insulin syringes to reduce dosing errors: a retrospective chart review of enoxaparin whole milligram dosing.
    Bauman ME; Black KL; Bauman ML; Belletrutti M; Bajzar L; Massicotte MP
    Thromb Res; 2009 Apr; 123(6):845-7. PubMed ID: 19038418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
    Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
    Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
    Blatný J; Fiamoli V
    Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
    Douketis J; Cook D; Meade M; Guyatt G; Geerts W; Skrobik Y; Albert M; Granton J; Hébert P; Pagliarello G; Marshall J; Fowler R; Freitag A; Rabbat C; Anderson D; Zytaruk N; Heels-Ansdell D; Crowther M;
    Arch Intern Med; 2008 Sep; 168(16):1805-12. PubMed ID: 18779469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter.
    O'Sullivan GJ; Lohan DG; Gough N; Cronin CG; Kee ST
    J Vasc Interv Radiol; 2007 Jun; 18(6):715-24. PubMed ID: 17538133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery.
    Akanmu AS; Nnodu OE; Giwa SO; Salako LA; Akinsete I; Adebule GT; Adekoya-Cole TO; Odunubi OO
    Afr J Med Med Sci; 2004 Dec; 33(4):335-40. PubMed ID: 15977441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis.
    Reiff DA; Haricharan RN; Bullington NM; Griffin RL; McGwin G; Rue LW
    J Trauma; 2009 May; 66(5):1436-40. PubMed ID: 19430251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital.
    Andrade-Campos MM; Montes-Limón AE; Fernandez-Mosteirin N; Salvador-Osuna C; Torres M; Lucia-Cuesta JF; Rubio-Felix D
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):194-8. PubMed ID: 23358201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.